Effect of Semet (80 and 160 mcg) Versus Placebo in Euthyroid Patients With AIT

NCT02302768 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Thyroiditis Autoimmune

Interventions

DIETARY_SUPPLEMENT: Selenomethionine
OTHER: Placebo

Sponsor

University of Siena

Collaborators

[object Object]